Fast-tracking leucovorin for autism may help families sooner, but a national evidence registry is needed to track how the drug performs in real life.
Something remarkable, and controversial, is unfolding in American medicine. The Food and Drug Administration says it is fast-tracking leucovorin, a long-established drug, for potential use in treating cerebral folate deficiency, a condition connected... [6271 chars]